943006-46-0 Usage
Uses
Used in Pharmaceutical Synthesis:
4-AMINO-6-IODO-2-METHYLPYRIMIDINE is used as a building block for the production of pharmaceuticals, contributing to the development of new drugs and therapeutic agents. Its unique structure allows it to be a key component in the synthesis of various organic compounds with potential medicinal applications.
Used in Agrochemical Production:
4-AMINO-6-IODO-2-METHYLPYRIMIDINE also serves as an intermediate in the manufacture of agrochemicals, playing a crucial role in the development of products designed to protect crops and enhance agricultural productivity.
Used in Dye and Pigment Manufacturing:
4-AMINO-6-IODO-2-METHYLPYRIMIDINE is utilized in the production of dyes and pigments, where its chemical properties contribute to the creation of a wide range of colorants for various industries, including textiles, plastics, and printing.
Safety Considerations:
4-AMINO-6-IODO-2-METHYLPYRIMIDINE is considered to have low toxicity, and when handled and used according to proper safety protocols, it does not pose significant health hazards. This makes it a relatively safe compound to work with in research and industrial settings.
Check Digit Verification of cas no
The CAS Registry Mumber 943006-46-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,3,0,0 and 6 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 943006-46:
(8*9)+(7*4)+(6*3)+(5*0)+(4*0)+(3*6)+(2*4)+(1*6)=150
150 % 10 = 0
So 943006-46-0 is a valid CAS Registry Number.
InChI:InChI=1/C5H6IN3/c1-3-8-4(6)2-5(7)9-3/h2H,1H3,(H2,7,8,9)
943006-46-0Relevant academic research and scientific papers
CALCIUM CHANNEL ANTAGONISTS
-
Page/Page column 33, (2010/11/27)
The present invention provides novel calcium channel antagonists, and methods of treating disease sates using the novel antagonists.
CALCIUM CHANNEL ANTAGONISTS
-
Page/Page column 8, (2010/11/28)
The present invention provides novel calcium channel antagonists, and methods of treating disease sates using the novel antagonists.
